In the Updated COVID-19 Treatment Guidelines on Prioritization of Anti-SARS-CoV-2 Monoclonal Antibodies for the Treatment or Prevention of SARS-CoV-2 Infection when there are Logistical or Supply Constraints, the COVID-19 Treatment Guidelines Panel recommends the use of anti-SARS-CoV-2 monoclonal antibodies (mAbs) for individuals who are at high risk for progression to severe COVID-19. Presenters on this […]